• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Vanguard Pharma

Anonymous board for Vanguard Pharma
Replies
2
Views
4K
anonymous
Replies
0
Views
3K
Anonymous
Replies
0
Views
3K
Anonymous